Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

Pregenerate

We accelerate drug development and personalized medicine for arthritis using disease-on-a-chip model
2019
11-50
Vienna, Wien, Austria

Investment Funding

Last Funding Stage

Convertible Note

Total Funding Amount

130.K

Last Funding Date

07-06-2022

Startup Stage

Seed

Lead Investors

SOSV, RebelBio

Revenue

$1M to $10M

People

Founders

Something missing or incorrect on this page? Help us enrich this information